Inter-Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials.

Kyriacou NM, Gross AS, McLachlan AJ

Open source

DOI
10.1111/cts.70224
Published
2025 May
Container
Clinical and translational science
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cts.70224,
  title = {Inter-Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials.},
  author = {Kyriacou NM and Gross AS and McLachlan AJ},
  year = {2025},
  journal = {Clinical and translational science},
  doi = {10.1111/cts.70224},
  url = {https://doi.org/10.1111/cts.70224}
}

RIS

TY  - JOUR
TI  - Inter-Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials.
AU  - Kyriacou NM
AU  - Gross AS
AU  - McLachlan AJ
PY  - 2025
JO  - Clinical and translational science
DO  - 10.1111/cts.70224
UR  - https://doi.org/10.1111/cts.70224
ER  - 

APA

NM, K., AS, G., & AJ, M. (2025). Inter-Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials.. Clinical and translational science. https://doi.org/10.1111/cts.70224

Source records